<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="been reported from other countries, allowing to speculate on pharmaceutical" exact="nicotine" post="as a potential treatment option in COVID-19 [24]. To"/>
 <result pre="on off-label use of old drugs, such as antimalarial drugs" exact="chloroquine" post="(CQ) and hydroxychloroquine (HCQ) and antiretroviral lopinavir/ritonavir and darunavir/cobicistat"/>
 <result pre="of old drugs, such as antimalarial drugs chloroquine (CQ) and" exact="hydroxychloroquine" post="(HCQ) and antiretroviral lopinavir/ritonavir and darunavir/cobicistat [26]. Unfortunately, conclusive"/>
 <result pre="et al. on the efficacy of the combination use of" exact="hydroxychloroquine" post="and azithromycin, which had great resonance and influenced treatment"/>
 <result pre="of current smoking among hospitalized COVID-19 patients in China: could" exact="nicotine" post="be a therapeutic option?Intern Emerg Med202010.1007/s11739-020-02355-732385628 24.PolosaRCaciGCOVID-19: counter-intuitive data"/>
 <result pre="COVID-19: a multidisciplinary point of viewClin Rheumatol20203972077208410.1007/s10067-020-05179-032472459 27.FaninACalegariJBeverinaAet al.Hydroxychloroquine and" exact="azithromycin" post="as a treatment of COVID-19Intern Emerg Med202010.1007/s11739-020-02388-y32474851 28.GautretPLagierJCParolaPet al.Clinical"/>
 <result pre="Med202010.1007/s11739-020-02388-y32474851 28.GautretPLagierJCParolaPet al.Clinical and microbiological effect of a combination of" exact="hydroxychloroquine" post="and azithromycin in 80 COVID-19 patients with at least"/>
 <result pre="al.Clinical and microbiological effect of a combination of hydroxychloroquine and" exact="azithromycin" post="in 80 COVID-19 patients with at least a six-day"/>
 <result pre="new treatment strategies for COVID-19: is there a role for" exact="bromhexine" post="as add-on therapy?Intern Emerg Med202010.1007/s11739-020-02383-332458206 30.LandiADe ServiSThe burden of"/>
</results>
